1 – 7 of 7
      - show: 10
- |
- sort: year (new to old)
        Close
        
            
    
    Embed this list
<iframe src=""
              width=""
              height=""
              allowtransparency="true"
              frameborder="0">
            </iframe>
        - 2024
- 
                        Mark
        Pre-clinical evaluation of clinically relevant iPS cell derived neuroepithelial stem cells as an off-the-shelf cell therapy for spinal cord injury
    
    - Contribution to journal › Article
 
- 2023
- 
                        Mark
        Advancing tomorrow’s therapies from research to reality : a comprehensive look at the ATMP pipeline at Lund Stem Cell Center
    (2023)- Book/Report › Report
 
- 2022
- 
                        Mark
        Multiple therapeutic effects of human neural stem cells derived from induced pluripotent stem cells in a rat model of post-traumatic syringomyelia
    
    - Contribution to journal › Article
 
- 2019
- 
                        Mark
        SQSTM1/p62-Directed Metabolic Reprogramming Is Essential for Normal Neurodifferentiation
    
    - Contribution to journal › Article
 
- 
                        Mark
        Single cell analysis of autism patient with bi-allelic NRXN1-alpha deletion reveals skewed fate choice in neural progenitors and impaired neuronal functionality
    
    - Contribution to journal › Article
 
- 2017
- 
                        Mark
        Integration Free Derivation of Human Induced Pluripotent Stem Cells Using Laminin 521 Matrix
    (2017) In Journal of visualized experiments : JoVE- Contribution to journal › Article
 
- 
                        Mark
        Derivation of human iPS cell lines from monozygotic twins in defined and xeno free conditions
    
    - Contribution to journal › Article
 
